Aurobindo Pharma announced a voluntary recall of one lot Gabapentin Capsules 300mg at the consumer level due to the discovery of some empty capsules.
The affected product has Lot #GESB14011-A, NDC# 16714-662-01, an expiration date of 12/2015, and is packaged in 100-count bottles. The recalled lot was distributed through the Northstar label to retail outlets across the country.
Gabapentin is approved for use in treatment of epilepsy and for the management of postherpetic neuralgia. Consuming empty capsules may lead to health consequences such as no effect, short-term reduction in efficacy, short-term withdrawal, or status epilepticus that may be life-threatening.
Aurobindo Pharma is contacting distributors and customers by letters and is arranging for return of all recalled product.
For more information call (732) 839-9400 or visit AurobindoUSA.com.